On Monday morning I saw ‘Bill’. He was pretty fed up. Ex-military, 85 years old and getting increasingly frail with a number of significant health problems, notably heart failure. In days gone by he was...
Incretin-based therapies like semaglutide and tirzepatide have taken the world by storm - splashed across headlines, hailed as game-changers, and now likely being discussed over brunch. But beneath the...
Some pieces of research completely change the way we think about a condition; some also completely change the way we manage a condition.
General practice can feel relentless. On bad days, back-to-back 10-minute appointments, endless admin, and always running behind can leave you feeling inefficient and overwhelmed. Suggesting to a frazzled...
Cancer diagnosis during pregnancy or in the post-partum period is thankfully a rare occurrence, with an estimated incidence of 1 in 1000 pregnancies in England. A key challenge is distinguishing symptoms...
Whilst we are (rightly) excited about the advent of the SGLT2 inhibitors as a drug class that can improve renal and cardiovascular outcomes in people with CKD, it’s important to remember that the SGLT2...